Global burden, inequality, and frontier gaps of autism spectrum disorder disability in adolescents and young adults, 1990-2021: a systematic analysis of the GBD 2021 study.
Lin Derong, Shi Zhuangtang, Hao Zhen, Xie Xiaohua, Fang Jingya, Li Mei, Zhang Weiqing, Luo Shuxiong, Xue Aiguo
What this study means for families
This large study looked at autism disability in teenagers and young adults (ages 15-39) worldwide from 1990-2021. While the total number of people with autism increased significantly, this was mainly due to population growth and better detection rather than more people developing autism. Males were affected about twice as much as females. Wealthier countries reported higher autism rates, possibly due to better diagnosis and services.
The study found big gaps between countries in autism support and identification.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Research summary
This systematic analysis of Global Burden of Disease 2021 data examined autism spectrum disorder (ASD) disability burden in adolescents and young adults (ages 15-39) across 204 countries from 1990-2021. The study found prevalent ASD cases increased from 17.52 to 24.13 million, with disability-adjusted life-years rising from 3.30 to 4.55 million. However, age-standardised rates remained relatively stable. Males accounted for approximately two-thirds of the burden (rate ratio ~2.1).
Higher sociodemographic development was associated with higher reported prevalence and disability rates. The study identified significant global inequalities in ASD burden, with several high-income countries exceeding optimal performance frontiers while some low-income countries showed surveillance gaps.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Key findings
- 1
ASD cases in adolescents and young adults increased from 17.52 to 24.13 million globally (1990-2021), but age-standardised rates remained stable
Confidence: strongRelevance: Indicates increased case detection and population growth rather than rising incidence - 2
Males contribute approximately two-thirds of ASD burden with a rate ratio of ~2.1 compared to females
Confidence: strongRelevance: Confirms persistent sex differences in ASD diagnosis and disability burden - 3
Higher sociodemographic development associated with higher reported ASD prevalence and disability rates
Confidence: strongRelevance: Suggests diagnostic and surveillance disparities between high and low-income countries - 4
Disability burden peaked most significantly in ages 30-39 years (+56% increase)
Confidence: moderateRelevance: Highlights need for adult-focused autism services and support systems
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Clinical implications
Results emphasize need for expanded adult autism screening and vocational support, particularly in ages 30-39. Global inequalities require strengthened surveillance systems and community-based interventions in low-resource settings. Economic development alone insufficient to reduce autism disability burden without targeted interventions.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Limitations
Study relies on Global Burden of Disease estimates which may have varying data quality across countries. Apparent low burden in some low-income countries likely reflects surveillance gaps rather than true low prevalence. Cross-country comparisons may be affected by differences in diagnostic practices and healthcare systems.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Original abstract
Autism spectrum disorder (ASD) ranks among the leading causes of years lived with disability in adolescence and young adulthood (AYA), yet global assessments still focus on childhood and seldom examine how national development modifies burden. We analysed Global Burden of Disease 2021 data for 204 countries and territories from 1990 to 2021. Among AYA aged 15-39 years, we extracted the age-standardised prevalence rate (ASPR) and disability-adjusted life-year rate (ASDR), stratified by sex, five-year age groups and Sociodemographic Index (SDI) quintile. Temporal trends were evaluated using the Estimated Annual Percentage Change (EAPC).
Cross-country absolute and relative inequalities were quantified with the Slope Index of Inequality (SII) and Concentration Index (CIX). A half-normal stochastic frontier model defined the minimum attainable ASDR for each SDI level; country-year gaps were calculated as observed minus frontier values. From 1990 to 2021, prevalent ASD cases increased from 17.52 to 24.13 million and DALYs from 3.30 to 4.55 million. Despite higher counts, global age-standardised rates changed little: in 2021 the ASPR was 811.67 per 100000 (95% UI 683.34-952.87) and ASDR 153.00 (95% UI 103.77-215.64); EAPCs were near zero.
Males contributed about two-thirds of the burden (rate ratio ≈2.1). Disability rose most at ages 30-39 (+56%). A persistent SDI gradient was observed: high-SDI settings recorded ASPR 1090.72 and ASDR 205.00 versus 845.15 and 158.57 in low-SDI settings. In 2021, SII was 22.53 (95% UI 12.53-32.53) and CIX 0.04 (95% UI 0.02-0.05).
Several high-income economies exceeded the frontier, while Bangladesh, Somalia and Niger lay on or below it-likely reflecting surveillance gaps rather than low burden. Absolute ASD disability in AYA has risen mainly from population growth and case detection, not higher per capita risk. A sustained male predominance, a renewed peak at ages 30-39, and minimal progress on inequality show that economic gains alone have not reduced burden. Expanding adult screening, vocational support and community-based interventions, alongside stronger surveillance and parent training in low-SDI settings, is required to narrow global gaps.
Evidence Grade
strong
Grade assigned by AutismInsights based on study type and published abstract.
Study Details
- Journal
- Frontiers in public health
- Year
- 2025
- PMID
- 41179783
- DOI
- 10.3389/fpubh.2025.1681565
MeSH Terms